Oramed Pharmaceuticals Inc. (ORMP)
PHARMACEUTICAL PREPARATIONS
Oramed Pharmaceuticals Inc. (ORMP) is listed on Nasdaq, where it has traded since April 19, 2004.
- Listed On
- Nasdaq
- Listed Since
- April 19, 2004
- Employees
- 13
- Market Cap
- $186M
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 83 institutions reported holding ORMP, with 16.8 million shares worth $80.7 million in aggregate. The largest reported holder was Mercer Global Advisors Inc /Adv, with 3.8 million shares worth $18.3 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Mercer Global Advisors Inc /Adv | 3,810,540 | $18M | Added 99.45% |
| Aquamarine Financial (Cayman) | 2,512,175 | $12M | Added 18.93% |
| Gem Investment Advisors | 1,998,802 | $10M | Added 21.87% |
| BlackRock | 1,608,111 | $8M | Added 1644.31% |
| Murchinson Ltd | 1,290,294 | $6M | Reduced 1.9% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ORMP?
Oramed Pharmaceuticals Inc. (ORMP) is listed on Nasdaq, where it has traded since April 19, 2004.
Who are the largest institutional holders of ORMP?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ORMP were Mercer Global Advisors Inc /Adv, Aquamarine Financial (Cayman) and Gem Investment Advisors.
How many institutions own ORMP?
83 institutions reported a position in ORMP for the quarter ended June 30, 2026, worth $80.7 million in total.
Did institutions buy or sell ORMP last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for ORMP.
Every reported institutional holder, plus insider and congressional trades in ORMP, on SentiSense.